Croda International (OTCMKTS:COIHD) Shares Down 0.5% - Should You Sell?

Key Points

• Shares fell 0.5% to $18.78 on Tuesday (intraday low $18.75) with volume of 18,440 shares — about a 791% jump versus the average session volume.
• Key valuation and technicals: market cap ~$4.83 billion, P/E 15.19, PEG 2.26, beta 0.53; the 50‑day moving average ($19.38) sits slightly above the 200‑day moving average ($18.74).
• Croda is a U.K. specialty chemicals company supplying ingredients and technologies for personal care, pharmaceuticals, agriculture and industrial applications, with global manufacturing and R&D operations.

Croda International Plc (OTCMKTS:COIHD - Get Free Report)'s stock price traded down 0.5% on Tuesday . The company traded as low as $18.75 and last traded at $18.78. 18,440 shares were traded during mid-day trading, an increase of 791% from the average session volume of 2,069 shares. The stock had previously closed at $18.8750.

Croda International Stock Down 0.5%

The company's 50-day moving average is $19.38 and its two-hundred day moving average is $18.74. The company has a market cap of $4.83 billion, a P/E ratio of 15.19, a price-to-earnings-growth ratio of 2.26 and a beta of 0.53.

About Croda International

Croda International is a global specialty chemicals company that develops, manufactures and supplies high-performance ingredients and technologies. Its product portfolio spans personal care surfactants and emollients, life sciences solutions for pharmaceuticals and agriculture, and performance additives for coatings, lubricants and industrial applications. The company's formulations are designed to improve product efficacy, sustainability and health outcomes across diverse end markets.

Founded in 1925 and headquartered in East Yorkshire, U.K., Croda operates a network of manufacturing and research facilities across Europe, North America, Latin America and the Asia-Pacific region.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.